Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLIRT-bevacizumab in MGMT Silenced, MSS Metastatic Colorectal Cancer
NCT04689347Phase 2Recruiting
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jan 2021
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in metastatic colorectal cancer (mCRC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jan 2021; status: recruiting.
02
Drugs
temozolomide
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT04689347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04689347.